Sep 06, 2017 11:05 am UTC| Business
SAN JUAN, Puerto Rico, Sept. 06, 2017 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) through its wholly-owned subsidiary, Project 1493 LLC, announced today that it has commenced...
Faron Pharmaceuticals Oy: Interim Results for the six months ended 30 June 2017
Sep 06, 2017 11:01 am UTC| Business
Faron Pharmaceuticals Ltd("Faron" or the "Company") Interim Results for the six months ended 30 June 2017 INTEREST Phase III Traumakine® trial patient recruitment to complete in Q4 2017 and FDA advice received...
Sep 06, 2017 11:01 am UTC| Business
Geneva, Switzerland and Boston, MA - 06 September, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions...
Sep 06, 2017 11:01 am UTC| Business
FREMONT, Calif., Sept. 06, 2017 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it has received a $900,000 order from one of its lead FOX-XP...
Shield Therapeutics plc ("Shield" or the "Group") US Composition of Matter Patent
Sep 06, 2017 11:01 am UTC| Business
LONDON, Sept. 06, 2017 -- Shield Therapeutics plc (LSE:STX), a specialty pharmaceutical company focused on secondary care, is pleased to announce that the United States Patent and Trademark Office (USPTO) has allowed a...
Sep 06, 2017 11:01 am UTC| Business
-- Study achieved statistical significance on all primary and secondary biological endpoints -- -- Results further validate the Company’s exon-skipping platform for the treatment of DMD -- CAMBRIDGE, Mass., Sept. 06,...
Sep 06, 2017 11:01 am UTC| Business
SAINT-GENIS-POUILLY, France, Sept. 06, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that the first...